Elaine V. Morlock - Publications

Molecular and Cellular Pharmacology University of Wisconsin, Madison, Madison, WI 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, et al. HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. Plos One. 7: e51301. PMID 23284679 DOI: 10.1371/journal.pone.0051301  0.84
2011 Morlock EV, Czajkowski C. Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding. Molecular Pharmacology. 80: 14-22. PMID 21447642 DOI: 10.1124/mol.110.069542  0.84
2009 Mason RA, Morlock EV, Karagas MR, Kelsey KT, Marsit CJ, Schned AR, Andrew AS. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis. 30: 1155-60. PMID 19372140 DOI: 10.1093/carcin/bgp077  0.84
2009 Andrew AS, Gui J, Sanderson AC, Mason RA, Morlock EV, Schned AR, Kelsey KT, Marsit CJ, Moore JH, Karagas MR. Bladder cancer SNP panel predicts susceptibility and survival. Human Genetics. 125: 527-39. PMID 19252927 DOI: 10.1007/s00439-009-0645-6  0.84
2008 Hanson SM, Morlock EV, Satyshur KA, Czajkowski C. Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. Journal of Medicinal Chemistry. 51: 7243-52. PMID 18973287 DOI: 10.1021/jm800889m  0.84
Show low-probability matches.